Asset
ABT-436
Abbott Laboratories Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01050127 | phase1 | completed | 2009-12-01 | 2010-02-01 | Abbott | A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of ABT-436 in Healthy Adults |
FDA applications (0)
This company has no applications containing this asset.